CA19-9 RIA FOR DIFFERENTIATION BETWEEN PANCREATIC ADENOCARCINOMA AND CHRONIC-PANCREATITIS ENDOCRINE PANCREATIC TUMORS

被引：0
|
作者：
KLAPDOR, R
LEHMANN, U
BAHLO, M
GRETEN, H
VONACKEREN, H
DALLEK, U
KRAAS, E
机构：
[1] UNIV KLINIKUM EPPENDORF,MED KERN & POLIKLIN,CHIRURG KLIN,HAMBURG,FED REP GER
[2] MARIENKRANKENHAUS,CHIRURG ABT,HAMBURG,FED REP GER
来源：
DIGESTION | 1983年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [41] Ca19-9 and pancreatic cancer: Is it really that good?
    Morris-Stiff, Gareth
    Taylor, Mark A.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2012, 3 (02) : 88 - 89
  • [42] IMMUNOHISTOCHEMICAL STAINING OF PANCREATIC-CANCER WITH CA19-9, KM01, UNABSORBED CEA, AND ABSORBED CEA - A COMPARISON WITH NORMAL PANCREAS AND CHRONIC-PANCREATITIS
    SHIMIZU, M
    SAITOH, Y
    OHYANAGI, H
    ITOH, H
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1990, 114 (02) : 195 - 200
  • [43] PANCREATIC-JUICE PROTEIN ASSOCIATED WITH CHRONIC-PANCREATITIS AND ADENOCARCINOMA OF THE PANCREAS
    SCHNEIDER, MU
    ROSCH, W
    DOMSCHKE, S
    DOMSCHKE, W
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1984, 19 (02) : 139 - 144
  • [44] DISTRIBUTION OF TYPE-IV COLLAGEN IN PANCREATIC ADENOCARCINOMA AND CHRONIC-PANCREATITIS
    LEE, CS
    MONTEBELLO, J
    GEORGIOU, T
    RODE, J
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 1994, 75 (02) : 79 - 83
  • [45] Accuracy of preoperative serum CA19-9 levels in predicting the resectability of patients with pancreatic adenocarcinoma
    Ying Li
    Xiaojuan Yang
    Zhanzhan Zhang
    Xiaoning Kang
    Shanglong Liu
    OncologyandTranslationalMedicine, 2018, 4 (01) : 6 - 9
  • [46] Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
    Kim, Young Choon
    Kim, Hong Joo
    Park, Jung Ho
    Park, Dong Il
    Cho, Yong Kyun
    Sohn, Chong Il
    Jeon, Woo Kyu
    Kim, Byung Ik
    Shin, Jun Ho
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (12) : 1869 - 1875
  • [47] EXPRESSION OF CA125 IN PANCREATIC-CARCINOMA AND CHRONIC-PANCREATITIS
    MACDONALD, F
    DOWNING, R
    ALLUM, WH
    BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 505 - 506
  • [48] PROGNOSTIC VALUE OF POST OPERATIVE CA19-9 IN PATIENTS UNDERGOING PANCREATICODUODENECTOMY FOR PANCREATIC ADENOCARCINOMA
    Malde, D. J.
    Jeans, E.
    De Liguori, N.
    Deshpande, R.
    Ammori, B. J.
    Sherlock, D. J.
    O'Reilly, D.
    GUT, 2012, 61 : A114 - A115
  • [49] CA19-9 Kinetics Following Radiation Therapy Correlate With Outcomes in Patients With Pancreatic Adenocarcinoma
    Shultz, D. B.
    Cato, C.
    Jenny, S. L.
    Koong, A. C.
    Daniel, C. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S314 - S315
  • [50] Clinical Utility of the Combined Use of CA19-9 and DUPAN-2 in Pancreatic Adenocarcinoma
    Sumiyoshi, Tatsuaki
    Uemura, Kenichiro
    Shintakuya, Ryuta
    Okada, Kenjiro
    Baba, Kenta
    Harada, Takumi
    Serikawa, Masahiro
    Ishii, Yasutaka
    Nakamura, Shinya
    Arihiro, Koji
    Murakami, Yoshiaki
    Takahashi, Shinya
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (07) : 4665 - 4672
12345